Shares of Abercrombie & Fitch soar 15%, as retailer blows past Wall Street’s expectations

Shares of Abercrombie & Fitch soar 15%, as retailer blows past Wall Street’s expectations


An Abercrombie & Fitch store in San Francisco.

Getty Images

Shares of Abercrombie & Fitch soared in premarket trading, after the retailer crushed Wall Street’s earnings and sales expectations for the quarter and raised its forecast for the year.

Here’s how the retailer did in the fiscal second quarter ended July 29 compared with what Wall Street expected, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.10 vs. 17 cents expected
  • Revenue: $935.3 million vs $842.4 million expected

Net income for the three-month period rose to $56.9 million, or $1.10 per share, from a loss of $16.8 million, or 33 cents a share, in the year-ago period.

Net sales rose from $805.1 million in the year prior.

Abercrombie said it now anticipates net sales will rise by about 10% for the full fiscal year, up from $3.7 billion in the prior year. It had previously expected growth of between 2% and 4%.

It said it expects operating margins to improve, too, as costs of freight and raw materials fall. It anticipates operating margins to be in the range of 8% to 9%, compared with prior expectations of 5% to 6%.

The retailer’s sales and its stock price have shot up, as Abercrombie has reinvented its image from a mall store known for shirtless models and a strong scent of cologne to a retailer that resonates with a broader audience.

As of Tuesday’s close, shares of Abercrombie had shot up about 80% this year, far outpacing the approximately 14% gains of the S&P 500. Shares of the company touched a 52-week high of $43.47 earlier this week.

Abercrombie also has stood out because it’s defied industry-wide trends. Retailers including Home Depot, Target and Walmart have all spoken about consumers who aren’t spending as freely on discretionary items, such as clothing. Foot Locker echoed similar sentiments, as its sales plummeted and it cut full-year guidance on Wednesday.

This is a developing story. Please check back for updates.



Source

Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch
Business

Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026. George Frey | Bloomberg | Getty Images Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company’s new GLP-1 pill […]

Read More
Trump’s proposed ban on buying single-family homes introduces uncertainty for family offices
Business

Trump’s proposed ban on buying single-family homes introduces uncertainty for family offices

Single-family homes in a residential neighborhood in Miramar, Florida, Oct. 27, 2022. Joe Raedle | Getty Images News | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Private investment […]

Read More
College students and teens could be fueling the prediction markets boom
Business

College students and teens could be fueling the prediction markets boom

A version of this article first appeared in the CNBC Sport newsletter with Alex Sherman, which brings you the biggest news and exclusive interviews from the worlds of sports business and media. Sign up to receive future editions, straight to your inbox. As prediction market trading volume booms, Truist analysts say there could be an unlikely source […]

Read More